AKKIZ, H. Et Al. 2010. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. CANCER EPIDEMIOLOGY , vol.34, no.4 , 448-452.

AKKIZ, H., Suembuel, A. T., Bayram, S., Bekar, A., & Akgoellue, E., (2010). MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. CANCER EPIDEMIOLOGY , vol.34, no.4, 448-452.

AKKIZ, HİKMET Et Al. "MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population," CANCER EPIDEMIOLOGY , vol.34, no.4, 448-452, 2010

AKKIZ, HİKMET Et Al. "MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population." CANCER EPIDEMIOLOGY , vol.34, no.4, pp.448-452, 2010

AKKIZ, H. Et Al. (2010) . "MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population." CANCER EPIDEMIOLOGY , vol.34, no.4, pp.448-452.

@article{article, author={HİKMET AKKIZ Et Al. }, title={MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population}, journal={CANCER EPIDEMIOLOGY}, year=2010, pages={448-452} }